Race Differences in Platelet Reactivity: Is Protease Activated Receptor 4 a Predictor of Response to Therapy?

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.114.304727
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation Is Dependant on Clopidogrel Response

Thrombosis Research
Hematology
2012English

Essential Role of Platelet Activation via Protease Activated Receptor 4 in Tissue Factor-Initiated Inflammation

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2008English

Thrombin Receptor Protease-Activated Receptor 4 Is a Key Regulator of Exaggerated Intimal Thickening in Diabetes Mellitus

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Erratum To: Protease-Activated-Receptor-2 Affects Protease-Activated-Receptor-1-Driven Breast Cancer

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Protease-Activated Receptor-4: A Novel Mechanism of Inflammatory Pain Modulation

British Journal of Pharmacology
Pharmacology
2007English

B2R of Bradykinin Activated by Proteases * Response: Does the Bradykinin B2 Receptor Function as a Protease-Activated Receptor?

Hypertension
Internal Medicine
2003English

The Decreased Expression of Protease-Activated Receptor 4 in Esophageal Squamous Carcinoma

Neoplasma
Cancer Research
2014English

Termination of Signaling by Protease-Activated Receptor-1 Is Linked to Lysosomal Sorting

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Protease-Activated Receptor 2 (PAR2)

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy